sodium salicylate has been researched along with sulfasalazine in 3 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (sulfasalazine) | Trials (sulfasalazine) | Recent Studies (post-2010) (sulfasalazine) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 4,437 | 585 | 938 |
Protein | Taxonomy | sodium salicylate (IC50) | sulfasalazine (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 1.5 | |
Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | 3 | |
Carbonic anhydrase 1 | Homo sapiens (human) | 3.04 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 4.49 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 6.332 | |
Sodium/bile acid cotransporter | Homo sapiens (human) | 9.6 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.46 | |
Cystine/glutamate transporter | Homo sapiens (human) | 0.16 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.56 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cronstein, BN; Montesinos, MC; Weissmann, G | 1 |
Hatala, DA; Howell, SJ; Huang, K; Kern, TS; Zheng, L | 1 |
Bau, JT; Kurz, EU | 1 |
3 other study(ies) available for sodium salicylate and sulfasalazine
Article | Year |
---|---|
Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB.
Topics: Adenosine Deaminase; Animals; Aspirin; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Female; Glucocorticoids; Inflammation; Isoenzymes; Leukocytes; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; NF-kappa B; NF-kappa B p50 Subunit; Prostaglandin-Endoperoxide Synthases; Protein Precursors; Purinergic P1 Receptor Antagonists; Salicylates; Sodium Salicylate; Sulfasalazine; Theobromine | 1999 |
Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Death; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Inflammation; Male; NF-kappa B; NF-kappa B p50 Subunit; Protein Transport; Random Allocation; Rats; Rats, Inbred Lew; Retina; Retinal Ganglion Cells; Salicylates; Sodium Salicylate; Sulfasalazine; Transcription Factor RelA | 2007 |
Structural determinants of the catalytic inhibition of human topoisomerase IIα by salicylate analogs and salicylate-based drugs.
Topics: Adenosine Triphosphate; Antigens, Neoplasm; Antineoplastic Agents; Biocatalysis; Diflunisal; DNA Fragmentation; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Catenated; DNA, Kinetoplast; DNA, Neoplasm; DNA, Superhelical; Doxorubicin; Enzyme Inhibitors; Humans; Hydrolysis; MCF-7 Cells; Models, Molecular; Molecular Conformation; Neoplasm Proteins; Plasmids; Salicylates; Sodium Salicylate; Sulfasalazine | 2014 |